abrdn Physical Palladium Shares ETF vs Health Care Select Sector SPDR Fund — how do they compare? abrdn Physical Palladium Shares ETF trades at $20.77 (market cap $586.03M), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 74.2× abrdn Physical Palladium Shares ETF's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold abrdn Physical Palladium Shares ETF for 33 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| PALL | XLV | |
|---|---|---|
Market Cap | $586.03M | $43.48B |
Volume | 1,257,028 | 11,121,431 |
Sector | Commodities - Metals/Agriculture | — |
52-Week High | $37.18 | $175.68 |
52-Week Low | $20.30 | $141.95 |
Typical Hold Time | 33 Days | 100 Days |
Signals from Pluang's Aura AI — not financial advice
PALL trades at $20.49, up 0.94% today, but faces strong bearish technical signals with 13 of 13 moving averages indicating sell signals. The ETF shows oversold conditions with RSI readings below 13, suggesting potential for a technical bounce. Recent news highlights palladium's underperformance relative to other precious metals, with some analysts viewing current weakness as a buying opportunity given supply risks and industrial demand fundamentals.
The outlook remains challenging with bearish technical momentum, though oversold conditions may provide short-term relief. Investment opportunity exists if palladium prices recover from current depressed levels, supported by supply constraints and industrial demand. Key risks include continued commodity price volatility and broader precious metals market dynamics that could pressure the ETF further.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →